Study may point to new treatment approach for ASD

November 17, 2017 by Bill Snyder, Vanderbilt University
Credit: CC0 Public Domain

Using sophisticated genome mining and gene manipulation techniques, researchers at Vanderbilt University Medical Center (VUMC) have solved a mystery that could lead to a new treatment approach for autism spectrum disorder (ASD).

Their findings, reported last month in the Journal of Neuroscience, broke new ground: for the first time a variation in a gene called ITGB3 was found to alter the supply of the in a mouse model of ASD.

ASD occurs predominantly in boys. About a third of people with ASD have elevated blood levels of serotonin. Variations in ITGB3 and in the gene for the (SERT), which regulates the serotonin supply, have previously been linked to the disorder.

ITGB3 is the gene for integrin subunit beta3, a receptor protein that, in platelets, plays a role in blood clotting. What role, if any, does it play in autism?

To find out, the researchers combed through Vanderbilt's DNA databank, BioVU, which links DNA samples to the electronic health record. They were looking for associations between a variation in ITGB3 that is commonly found in people with ASD and neuropsychiatric disorders.

They got two strong hits in males but not females: attention deficit hyperactivity disorder (ADHD) and ASD.

The researchers then turned to a mouse model that expressed the beta3 variant. They found male mice with beta3 variant, but not females, exhibited autistic-like behaviors and increased blood serotonin levels.

When they blocked an enzyme known to be activated by integrin beta3, brain serotonin function in the animals returned to normal, said Ana Carneiro, PhD, assistant professor of Pharmacology at Vanderbilt.

This suggests integrin beta3 may be a potential treatment target for autism, said Carneiro's colleague in the study, James Sutcliffe, PhD, associate professor of Molecular Physiology and Biophysics and of Psychiatry and Behavioral Sciences. But it also raises more questions.

Variations in ITGB3 are sufficient to affect . "But what's causing the social deficits in autism?" Carneiro asked. "Is it a serotonin problem or is it an integrin problem?" Or, in some cases, is it both? Those are the next questions to be addressed.

SERT has long been linked to ASD. Anti-depressive drugs called selective serotonin reuptake inhibitors or SSRIs, which increase the brain's supply of serotonin by blocking SERT, can relieve some of the rigid-compulsive traits and social communication deficits that characterize ASD.

"Now we have a model that 'pheno-copies' multiple aspects of what we see in humans," she said. The hope is that the will help solve the mysteries of ASD, including why males are more likely to develop the disorder than females.

The latest findings are the culmination of more than a decade of painstaking work. In 2006 Sutcliffe and colleagues at Vanderbilt and the University of Chicago first reported that ITGB3 was associated with people with ASD who also had elevated blood levels of .

Two years later Carneiro and her colleagues, working in a separate lab at Vanderbilt, reported that integrin beta3 physically associates with and regulates SERT activity in platelets.

Explore further: Novel mouse model for autism yields clues to a 50-year-old mystery

More information: Michael R. Dohn et al. The Gain-of-Function Integrin β3 Pro33 Variant Alters the Serotonin System in the Mouse Brain, The Journal of Neuroscience (2017). DOI: 10.1523/JNEUROSCI.1482-17.2017

Related Stories

Novel mouse model for autism yields clues to a 50-year-old mystery

March 20, 2012
Early disruptions in serotonin signaling in the brain may contribute to autism spectrum disorder (ASD), and other "enduring effects on behavior," Vanderbilt University researchers report.

Researchers confirm the biochemical cause of seasonal depression

October 20, 2014
New research confirms why some people suffer from the winter blues while others get through the winter without any problems. A longitudinal study from a group of researchers from the University of Copenhagen has found that ...

GI problems in autism may originate in genes, study suggests

April 25, 2016
Researchers at Columbia University Medical Center (CUMC) have found evidence in mice that, for some types of autism, gastrointestinal difficulties may originate from the same genetic changes that lead to the behavioral and ...

Recommended for you

Forty percent of people have a fictional first memory, says study

July 17, 2018
Researchers have conducted one of the largest surveys of people's first memories, finding that nearly 40 per cent of people had a first memory which is fictional.

Protein found to be key component in irregularly excited brain cells

July 17, 2018
In a new study in mice, researchers have identified a key protein involved in the irregular brain cell activity seen in autism spectrum disorders and epilepsy. The protein, p53, is well-known in cancer biology as a tumor ...

Insight without incision: Advances in noninvasive brain imaging offers improvements to epilepsy surgery

July 17, 2018
About a third of epilepsy sufferers require treatment through surgery. To check for severe epilepsy, clinicians use a surgical procedure called electrocorticography (ECoG). An ECoG maps a section of brain tissue to help clinicians ...

New drug target for remyelination in MS is identified

July 17, 2018
Remyelination, the spontaneous regeneration of the fatty insulator in the brain that keeps neurons communicating, has long been seen as crucial to the next big advance in treating multiple sclerosis (MS). However, a lack ...

Artificial neural networks now able to help reveal a brain's structure

July 17, 2018
The function of the brain is based on the connections between nerve cells. In order to map these connections and to create the connectome, the "wiring diagram" of a brain, neurobiologists capture images of the brain with ...

Convergence of synaptic signals is mediated by a protein critical for learning and memory

July 16, 2018
Inside the brain, is a complex symphony of perfectly coordinated signaling. Hundreds of different molecules amplify, modify and carry information from tiny synaptic compartments all the way through the entire length of a ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.